Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UT-15C SR Added to Tyvaso in PAH
NCT01477333Phase 2Completed
- Sponsor
- United Therapeutics Corporation
- Start
- Oct 2011
- Primary completion
- Nov 2013
- Countries
- 1
01
Overview
A Phase 2 trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by United Therapeutics Corporation. Started Oct 2011; status: completed.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01477333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01477333.